10x Genomics has marked a new phase in its remarkable expansion by opening a modern office building that has just sprouted in Pleasanton.

PLEASANTON — 10x Genomics has crafted plans for a major expansion of its Pleasanton operations through the purchase of a big property that it will develop as a modern campus, the biotech company said ...

10x Genomics (NASDAQ: TXG), a biotechnology company that designs and manufactures gene sequencing technology, was listed following its IPO in September.

10x Genomics (TXG) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...

10x Genomics Inc is a life science technology company based in the United States. It offers a range of solutions, including instruments, consumables, and software for analyzing biological systems.

10x Genomics (NASDAQ: TXG), a biotechnology company that designs and manufactures gene sequencing technology, was listed following its IPO in September. While the stock saw some volatility post ...

As per our database, 17 hedge fund portfolios held 10x Genomics, Inc. (NASDAQ:TXG) at the end of the second quarter which was 22 in the previous quarter.

In one of the largest office leases in the East Bay this year, 10x Genomics grabbed a large chunk of space in Pleasanton for a new headquarters.

Life-sciences technology startup 10x Genomics Inc. said its initial public offering was priced above the high end of the expected range, giving it a valuation topping $3.6 billion.

On Jan. 25, 10x Genomics paid $29.4 million in cash for a 14.6-acre site at 1701 Springdale Ave., where the company will develop a second office campus in Pleasanton.

10x Genomics has crafted plans for a major expansion of its Pleasanton operations through the purchase of a big property that it will develop as a modern campus.